Showing all 7 results
Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefopodoxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 100 mg The Pediatric & Titration Anchor: Ideal for Pharyngitis, Tonsillitis, and uncomplicated UTIs in adolescents and adults. Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The Respiratory Macrodose: High-efficacy payload for Community-Acquired Pneumonia and Sinusitis. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing micronized API and specialized surfactants to overcome the naturally poor solubility of the Proxetil salt. Cefpodoxime Proxetil Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 50 mg / 100 mg The Pediatric & Titration Anchor: Dispersible format for easy administration in children and elderly patients with swallowing difficulties. Excipients Sweetening & Flavoring Agents Bitter-Shield Technology: Engineered with molecular masking agents (e.g., Cyclodextrins) to neutralize the intense bitterness of the API, ensuring 100% pediatric compliance. Disintegrants Croscarmellose Sodium / SSG Instant-Dispersible Matrix: Engineered to shatter and form a uniform suspension in < 60 seconds when placed in 5-10 mL of water. Ceftriaxone & Tazobactam Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. The standard ratio is 8:1.
Strength Variant Ceftriaxone Content Tazobactam Content Ratio 1.125 g Vial 1000 mg (1 g) 125 mg (Sodium) 8:1 (Standard) 562.5 mg Vial 500 mg 62.5 mg Pediatric Excipients None (Sterile Blend) – – *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
Cefuroxime Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Cefuroxime Sodium USP/BP Equivalent to 750 mg Cefuroxime Standard Adult Dose Cefuroxime Sodium USP/BP Equivalent to 1500 mg (1.5 g) Severe Infections / Surgery Excipients None (Pure Sterile Powder) – *Pack Sizes: Tray of 1 Vial, 10 Vials, 50 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
